Eishi Ashihara

Kyoto, 6078414, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 76 publications

Pharmacological regulation of airway ciliary motility: endogenous mediators, pharmaceutical agents, and natural compounds with a focus on ginsenoside Rd.

Pharmacological regulation of airway ciliary motility: endogenous mediators, pharmaceutical agents, and natural compounds with a focus on ginsenoside Rd.

Journal: Journal of natural medicines

Published: February 26, 2026

Y-box Binding Protein 1 as a Target Molecule of a Novel Coumarin-based Anti-metastatic Agent.

Y-box Binding Protein 1 as a Target Molecule of a Novel Coumarin-based Anti-metastatic Agent.

Journal: Anticancer research

Published: February 21, 2026

Ginsenoside Rd Improves Anticancer Drug-induced Disturbance in Murine Airway Ciliary Motility.

Ginsenoside Rd Improves Anticancer Drug-induced Disturbance in Murine Airway Ciliary Motility.

Journal: Anticancer research

Published: October 13, 2025

17β-estradiol (E2) increases ciliary beat frequency via membrane estrogen receptor β.

17β-estradiol (E2) increases ciliary beat frequency via membrane estrogen receptor β.

Journal: The Journal of steroid biochemistry and molecular biology

Published: June 21, 2025

Ginsenoside Rd Activates Ciliary Beat Frequency via Estrogen Receptor β and P2X7 Receptor.

Ginsenoside Rd Activates Ciliary Beat Frequency via Estrogen Receptor β and P2X7 Receptor.

Journal: Biological & pharmaceutical bulletin

Published: May 21, 2025

Akt Regulates Extracellular Vesicle Secretion in Hypoxia-adapted Multiple Myeloma RPMI8226 Cells.

Akt Regulates Extracellular Vesicle Secretion in Hypoxia-adapted Multiple Myeloma RPMI8226 Cells.

Journal: Anticancer research

Published: February 03, 2025

Cynaropicrin Increases [Ca2+]i and Ciliary Beat Frequency in Human Airway Epithelial Cells by Inhibiting SERCA.

Cynaropicrin Increases [Ca2+]i and Ciliary Beat Frequency in Human Airway Epithelial Cells by Inhibiting SERCA.

Journal: Biological & pharmaceutical bulletin

Published: December 22, 2024

Compound #41 Targets Acute Myelogenous Leukemia by Inhibiting the Wnt/β-catenin Signaling Pathway.

Compound #41 Targets Acute Myelogenous Leukemia by Inhibiting the Wnt/β-catenin Signaling Pathway.

Journal: Anticancer research

Published: September 15, 2024

Occurrence of respiratory and urinary tract infections in patients treated with docetaxel compared with afatinib based on a health insurance claims database in Japan.

Occurrence of respiratory and urinary tract infections in patients treated with docetaxel compared with afatinib based on a health insurance claims database in Japan.

Journal: International journal of clinical pharmacy

Published: January 22, 2024

Linderapyrone analogue LPD-01 as a cancer treatment agent by targeting importin7.

Linderapyrone analogue LPD-01 as a cancer treatment agent by targeting importin7.

Journal: Journal of natural medicines

Published: November 11, 2023

POLD1 Is Required for Cell Cycle Progression by Overcoming DNA Damage in Malignant Pleural Mesothelioma.

POLD1 Is Required for Cell Cycle Progression by Overcoming DNA Damage in Malignant Pleural Mesothelioma.

Journal: Cancer genomics & proteomics

Published: October 19, 2023

Depletion of DNTTIP2 Induces Cell Cycle Arrest in Pancreatic Cancer Cells.

Depletion of DNTTIP2 Induces Cell Cycle Arrest in Pancreatic Cancer Cells.

Journal: Cancer genomics & proteomics

Published: October 08, 2023

Showing 1-12 of 76

Last Updated: 09/26/2026